Potassium channel remodeling in cardiac hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 5, 2006, Pages 753-761

  Furukawa, Tetsushi ^a   Kurokawa, Junko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Arrhythmia; Calcineurin; Ion channel; Myocardial infarction; NFAT3

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN A RECEPTOR ANTAGONIST; IRBESARTAN; MINERALOCORTICOID ANTAGONIST; POTASSIUM CHANNEL; TRANSCRIPTION FACTOR NFAT;

BIOLOGICAL MODEL; CALCIUM TRANSPORT; CHANNEL GATING; DISEASE MODEL; ELECTROSTIMULATION; ENDOCARDIUM; EPICARDIUM; GENETIC ENGINEERING; GENETIC HETEROGENEITY; HEART ARRHYTHMIA; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART FUNCTION TEST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WORK; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAMMAL; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SUDDEN DEATH;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIA; CALCIUM; CARDIOMEGALY; DEATH, SUDDEN, CARDIAC; DISEASE MODELS, ANIMAL; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; POTASSIUM CHANNELS; RNA, MESSENGER;

EID: 33750285476     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.07.021     Document Type: Review

References (139)

1. Kannel W.B. Incidence and epidemiology of heart failure. Heart Failure Rev. 5 (2000) 167-173
2. Kannel W.B., McGee D.L., and Schatzkin A. An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study. Drugs 28 Suppl. 1 (1984) 1-16
3. Haider A.W., Larson M.G., Benjamin E.J., and Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J. Am. Coll. Cardiol. 32 (1998) 1454-1459
4. Boyden P.A., and Jeck C.D. Ion channel function in disease. Cardiovasc. Res. 29 (1995) 312-318
5. Wickenden A.D., Japrielian R., Kassiri Z., Tsoporis J.N., Tsushima R., Fishman G.I., et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc. Res. 37 (1998) 312-323
6. Nabauer M., and Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc. Res. 37 (1998) 324-334
7. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79 (1999) 215-262
8. Uhley H.N. Study of the transmembrane action potential, electrogram, electrocardiogram, and ventrocardiogram of rats with left ventricular hypertrophy. Am. J. Cardiol. 7 (1961) 211-217
9. Bassett A.L., and Gelband H. Chronic partial occlusion of the pulmonary artery in cats. Change in ventricular action potential configuration during early hypertrophy. Circ. Res. 32 (1973) 15-26
10. Bassett A.L., and Gelband H. Electrical and mechanical properties of cardiac muscle during chronic right ventricular pressure overload. Recent Adv. Stud. Cardiac Struct. Metab. 4 (1974) 3-20
11. Kleiman R.B., and Houser S.R. Outward currents in normal and hypertrophied feline ventricular myocytes. Am. J. Physiol. 256 (1989) H1450-H1461
12. Kleiman R.B., and Houser S.R. Outward currents in hypertrophied feline ventricular myocytes. Prog. Clin. Biol. Res. 334 (1990) 65-83
13. Furukawa T., Bassett A.L., Furukawa N., Kimura S., and Myerburg R.J. The ionic mechanism of reperfusion-induced early afterdepolarizations in feline left ventricular hypertrophy. J. Clin. Invest. 91 (1993) 1521-1531
14. K differs in feline left ventricular hypertrophy. Am. J. Physiol. 266 (1994) H1121-H1131
15. Ten Eick R.E., Zhang K., Harvey R.D., and Bassett A.L. Enhanced functional expression of transient outward current in hypertrophied feline myocytes. Cardiovasc. Drugs Ther. Suppl. 3 (1993) 611-619
16. Volders P.G., Sipido K.R., Vos M.A., Kulcsar A., Verduyn S.C., and Wellens H.J. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation 98 (1998) 1136-1147
17. Ks in canine hypertrophied hearts. Cardiovasc. Res. 57 (2003) 486-496
18. + currents among the left ventricular free wall of rats with ascending aortic stenosis. J. Physiol. 530 (2001) 443-455
19. Gomez A.M., Benitah J.P., Henzel D., Vinet A., Lorente P., and Delgado C. Modulation of electrical heterogeneity by compensated hypertrophy in rat left ventricle. Am. J. Physiol. 272 (1997) H1078-H1086
20. Tomita F., Bassett A.L., Myerburg R.J., and Kimura S. Diminished transient outward currents in rat hypertrophied ventricular myocytes. Circ. Res. 75 (1994) 296-303
21. Coulombe A., Momtaz A., Richer P., Swynghedauw B., and Coraboeuf E. Reduction of calcium-independent transient outward potassium current density in DOCA salt hypertrophied rat ventricular myocytes. Pflughers Arch. 427 (1994) 47-55
22. Momtaz A., Coulombe A., Richer P., Mercadier J.J., and Coraboeuf E. Action potential and plateau ionic currents in moderately and severely DOCA-salt hypertrophied rat hearts. Mol. Cell. Cardiol. 28 (1996) 2511-2522
23. Cerbai E., Barbieri M., Li Q., and Mugelli A. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc. Res. 28 (1994) 1180-1187
24. Meszaros J., Ryder K.O., and Hart G. Transient outward current in catecholamine-induced cardiac hypertrophy in the rat. Am. J. Physiol. 271 (1996) H2360-H2367
25. to1 density in hypertrophied right ventricular cells by simulated high altitude in adult rats. J. Mol. Cell. Cardiol. 29 (1997) 193-206
26. Lee J.K., Kodama I., Honjo H., Anno T., Kamiya K., and Toyama J. Stage-dependent changes in membrane currents in rats with monocrotaline-induced right ventricular hypertrophy. Am. J. Physiol. 272 (1997) H2833-H2842
27. + current in ventricular myocytes from acromegalic rats. Am. J. Physiol. 260 (1991) H935-H942
28. Ponteau D., Gomez J.P., and Fares N. Depressed transient outward current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovasc. Res. 30 (1995) 440-448
29. Eghbali M., Deva R., Alioua A., Minosyan T.Y., Ruan H., Wang Y., et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ. Res. 96 (2005) 1208-1216
30. Knollmann B.C., Knollmann-Ritschel B.E., Weissman N.J., Jones L.R., and Morad M. Remodeling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J. Physiol. 525 (2000) 483-498
31. Mitarai S., Reed T.D., and Yatani A. Changes in ionic currents and beta-adrenergic receptor signaling in hypertrophied myocytes overexpressing Gαq. Am. J. Physiol. 279 (2000) H139-H148
32. Heath B.M., Xia J., Dong E., An R.H., Brooks A., Liang C., et al. Overexpression of nerve growth factor in the heart alters ion channel activity and beta-adrenergic signaling in an adult transgenic mouse. J. Physiol. 512 (1998) 779-791
33. + current changes and action potential duration. J. Am. Coll. Cardiol. 41 (2003) 1611-1622
34. Petkova-Kirova P.S., Gursoy E., Mehdi H., McTiernan C.F., London B., and Salama G. Electrical remodeling of cardiac myocytes from mice with heart failure due to overexpression of tumor necrosis factor-α. Am. J. Physiol. 290 (2006) H2098-H2107
35. to) phenotypes and distribution of fast-inactivating potassium channel α subunits in ferret left ventricular myocytes. J. Gen. Physiol. 113 (1999) 581-600
36. Tsuji Y., Opthof T., Yasui K., Inden Y., Takemura H., Niwa N., et al. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbit with chronic complete atrioventricular block. Circulation 106 (2002) 2012-2018
37. McIntosh M.A., Cobbe S.M., Kane K.A., and Rankin A.C. Action potential prolongation and potassium currents in left-ventricular myocytes isolated from hypertrophied rabbit hearts. J. Mol. Cell. Cardiol. 30 (1998) 43-53
38. Gillis A.M., Mathison H.J., Kulisz E., and Lester W.M. Dispersion of ventricular repolarization in left ventricular hypertrophy: influence of afterload and dofetilide. J. Cardiovasc. Electrophysiol. 9 (1998) 988-997
39. Gillis A.M., Goenzon R.A., Mathison H.J., Kulisz E., Lester W.M., and Duff H.J. The effects of barium, dofetilide and 4-aminopyridine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart. J. Pharmacol. Exp. Ther. 285 (1998) 262-270
40. Kaab S., Dixon J., Duc J., Ashen D., Nabauer M., Beuckelmann D.J., et al. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98 (1998) 1383-1393
41. Li G.R., Lau C.P., Leung T.K., and Nattel S. Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm 4 (2004) 460-468
42. 2+ currents in cells that survived in the epicardial border zone of canine healed infracted heart. Am. J. Physiol. 287 (2004) H1046-H1054
43. Jiang M., Cabo C., Yao J., Boyden P.A., and Tseng G. Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infracted canine ventricles. Cardiovasc. Res. 48 (2000) 34-43
44. Dun W., and Boyden P.A. Diverse phenotypes of outward currents in cells that have survived in the 5-day-infarcted heart. Am. J. Physiol. 289 (2005) H667-H673
45. Qin D., Zhang Z.H., Caref E.B., Boutjdir M., Jain P., and El-Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ. Res. 79 (1996) 461-473
46. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ. Res. 79 (1996) 669-675
47. + current of ventricular myocytes in rats with chronic myocardial infarction. Am. J. Physiol. 274 (1998) H259-H265
48. 2+]i in rat ventricular myocytes following myocardial infarction. J. Physiol. 517 (1999) 229-245
49. Yao J.A., Jiang M., Fan J.S., Zhou Y.Y., and Tseng G.N. Heterogeneous changes in K currents in rat ventricles three days after myocardial infarction. Cardiovasc. Res. 44 (1999) 132-145
50. + channel genes and currents in the postinfarction heart. J. Cardiovasc. Electrophysiol. 11 (2000) 1252-1261
51. K and its response to quinidine in experimental healed myocardial infarction. J. Cardiovasc. Electrophyiol. 10 (1999) 844-854
52. Anversa P., Beghi C., Kikkawa Y., and Olivetti G. Myocardial infarction in rats. infarct size, myocytes hypertrophy, and capillary growth. Circ. Res. 58 (1986) 26-37
53. Patterson E., Holland K., Eller B.T., and Lucchesi B.R. Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. Am. J. Cardiol. 50 (1982) 1414-1423
54. Furukawa T., Moroe K., Mayrovitz H.N., Sampsell R., Furukawa N., and Myerburg R.J. Arrhythmogenic effects of graded coronary blood flow reductions superimposed on prior myocardial infarction in dogs. Circulation 84 (1991) 368-377
55. + currents. Circ. Res. 90 (2002) 586-593
56. + channels in the rat. Mol. Cell. Biochem. 237 (2002) 1-10
57. + channel subunit mRNA in ventricles of renovascular hypertensive rats. Circ. Res. 81 (1997) 533-539
58. + channel expression by myocardial hypertrophic factors in cultured newborn rat ventricular cells. J. Mol. Cell. Cardiol. 30 (1998) 1449-1455
59. An W.F., Bowlby M.R., Betty M., Cao J., Ling H.P., Mendoza G., et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 403 (2000) 553-556
60. Nerbonne J.M., and Kass R.S. Molecular physiology of cardiac repolarization. Physiol. Rev. 85 (2005) 1205-1253
61. to and confers susceptibility to ventricular tachycardia. Cell 107 (2001) 801-813
62. Jia Y., and Takimoto K. Mitogen-activated protein kinases control cardiac KChIP2 gene expression. Circ. Res. 98 (2006) 386-393
63. Walsh K.B., Sweet J.K., Parks G.E., and Long K.J. Modulation of outward potassium currents in aligned cultures of neonatal rat ventricular myocytes during phorbol ester-induced hypertrophy. J. Mol. Cell. Cardiol. 33 (2001) 1233-1247
64. Ojamaa K., Kenessey A., Shenoy R., and Klein I. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am. J. Endocrinol. Metab. 279 (2000) E1319-E1324
65. Matsubara H., Suzuki J., and Inada M. Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy. J. Clin. Invest. 92 (1993) 1659-1666
66. Abe A., Yamamoto T., Isome M., Ma M., Yaoita E., Kawasaki K., et al. Thyroid hormone regulates expression of shaker-related potassium channel mRNA in rat heart. Biochem. Biophys. Res. Commun. 245 (1998) 226-230
67. + channels. J. Mol. Cell. Cardiol. 39 (2005) 121-132
68. Dixon J.E., and McKinnon D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats. Circ. Res. 75 (1994) 252-260
69. + channels?. Circ. Res. 77 (1995) 361-369
70. + current in cultured adult human atrial myocytes. Circ. Res. 80 (1997) 572-579
71. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ. Res. 80 (1997) 772-781
72. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
73. Deng L., Huang B., Qin D., Ganguly K., and El-Sherif N. Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling. J. Cardiovasc. Electrophysiol. 12 (2001) 1055-1061
74. Hogan P.G., Chen L., Nardone J., and Rao A. Transcriptional regulation by calcium, calcineruin, and NFAT. Genes Dev. 17 (2003) 2205-2232
75. Morin S., Charron F., Robitaille L., and Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19 (2000) 2046-2055
76. + currents after myocardial infarction. Circ. Res. 94 (2004) 1340-1350
77. Xia Y., McMillin J.B., Lewis A., Moore M., Zhu W.G., Williams R.S., et al. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and upregulates the adenylosuccinate synthetase 1 gene. J. Biol. Chem. 275 (2000) 1855-1863
78. 2+ signaling in cardiac myocytes excitation-transcription coupling. J. Clin. Invest. 116 (2006) 675-681
79. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., and Molkentin J.D. Myocyte enhancer factors 2A and 2C induced dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281 (2006) 9152-9162
80. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
81. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylases 5. Mol. Cell. Biol. 24 (2004) 8374-8385
82. McKinsey T.A., Zhang C.L., Lu J., and Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408 (2000) 106-111
83. van Oort R.J., van Rooji E., Bourajjaj M., Schimmel J., Jansen M.A., Nagel vanderR., et al. MEF2 activates a genetic program promoting chamber dilatation and contractile dysfunction in calcineruin-induced heart failure. Circulation 114 (2006) 298-308
84. Zhang T.T., Takimoto K., Stewart A.F., Zhu C., and Levitan E.S. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ. Res. 88 (2001) 476-482
85. Zhou C., Ziegler C., Birder L.A., Stewart A.F., and Levitan E.S. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ. Res. 98 (2006) 1040-1047
86. + channel remodeling in postinfarction rat heart. Circ. Res. 567 (2005) 177-190
87. + channel remodeling in rat ventricle. J. Mol. Cell. Cardiol. 40 (2006) 339-349
88. Flescher E., Tripoli H., Salnikow K., and Burns F.J. Oxidative stress suppresses transcription factor activities in stimulated lymphocytes. Clin. Exp. Immunol. 112 (1998) 242-247
89. Litovsky S.H., and Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ. Res. 62 (1998) 116-126
90. Furukawa T., Myerburg R.J., Furukawa N., Bassett A.L., and Kimura S. Differences in transient outward currents in feline endocardial and epicardial myocytes. Circ. Res. 67 (1990) 1287-1291
91. Fedida D., and Giles W.R. Regional variations in action potentials and transient outward current in myocytes isolated from rabbit left ventricle. J. Physiol. 442 (1991) 191-209
92. Bryant S.M., Shipsey S.J., and Hart G. Normal regional distribution of membrane current density in rat left ventricle is altered in catecholamine-induced hypertrophy. Cardiovasc. Res. 42 (1999) 391-401
93. Rosati B., Pan Z., Lypen S., Wang H.S., Cohen I., Dixon J.E., et al. Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. J. Physiol. 533 (2001) 119-125
94. Rosati B., Grau F., Rodriguez S., Li H., Nerbonne J.M., and McKinnon D. Concordant expression of KChIP2 mRNA, protein and transient outward current throughout the canine ventricle. J. Physiol. 548 (2003) 815-822
95. Zicha S., Xiao L., Stafford S., Cha T.J., Han W., Varro A., et al. Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts. J. Physiol. 561 (2004) 735-748
96. Costantini D.L., Arruda E.P., Agarwal O., Kim K.H., Zhu Y., Zhu W., et al. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123 (2005) 347-358
97. to transmural gradient in the mouse heart. Circ. Res. 98 (2006) 1306-1313
98. 2+ influx in epicardial myocytes of the rat left ventricle. Exp. Physiol. 90 (2005) 111-121
99. + current: a potential mechanism of the proarrhythmic effects of methanesulfonanilide class III agents. Cardiovasc. Res. 43 (1999) 135-147
100. I transients. Am. J. Physiol. 283 (2002) H1157-H1168
101. Barry D.M., Xu H., Schuessler R.B., and Nerbonne J.M. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 α subunit. Circ. Res. 83 (1998) 560-567
102. to,f and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ. Res. 97 (2005) 1342-1350
103. + channel subunit in the mouse heart. Circ. Res. 85 (1999) 1067-1076
104. to causes hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 90 (2002) 578-585
105. Zobel C., Kassiri Z., Nguyen T.T., Meng Y., and Backx P.H. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Circulation 106 (2002) 2385-2391
106. Lebeche D., Kaprielian R., and Hajjar R. Modulation of action potential duration on myocytes hypertrophic pathway. J. Mol. Cell. Cardiol. 40 (2006) 725-735
107. Lebeche D., Kaprielian R., del Monte F., Tomaselli G., Gwathmey J.K., Schwartz A., et al. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 110 (2004) 3435-3443
108. + current and cardiac hypertrophy. Causal relationship or epiphenomenon?. Circ. Res. 90 (2002) 497-499
109. Lynch Jr. J.J., Sanguinetti M.C., Kimura S., and Bassett A.L. Therapeutic potential of modulating potassium currents in the diseases myocardium. FASEB J. 6 (1992) 2952-2960
110. Shieh C.C., Coghlan N., Sullivan J.P., and Gopalakrishman M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 52 (2000) 557-594
111. Ks corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. Am. J. Physiol. 283 (2002) H664-H670
112. Wasson S., Reddy H.K., and Dohrmann M.L. Current perspectives of electrical remodeling and its therapeutic implications. J. Cardiovasc. Pharmacol. Ther. 9 (2004) 129-144
113. Lubic S.O., Giacomini K.M., and Giacomini J.C. The effects of modulation of calcium influx through the voltage-sensitive calcium channel on cardiomyocytes hypertrophy. J. Moll. Cell. Cardiol. 27 (1995) 917-925
114. Walsh K.B., and Kass R.S. Regulation of a heart potassium channel by protein kinase A and C. Science 242 (1998) 67-69
115. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295 (2002) 496-499
116. 2+- and protein kinase C-dependent mechanism. Am. J. Physiol. 280 (2001) H1528-H1536
117. 2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method. Pflughers Arch. 444 (2002) 107-116
118. Furukawa T., Ito H., Nitta J., Tsujino M., Adachi S., Hiroe M., et al. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ. Res. 71 (1992) 1242-1253
119. 2+ current in ventricular cardiomyocytes. Eur. J. Pharmacol. 308 (1996) 351-355
120. 2+ channels via phosphorylation of serine 1829 in the rabbit Cav1.2 subunit. Circ. Res. 94 (2004) 1242-1248
121. 2+ current in adult rat cardiomyocytes. Circ. Res. 85 (1999) 1139-1145
122. Lalevee N., Bebsamen M.C., Barrere-Lemaire S., Perrier E., Nargeot J., Benitah J.P., et al. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc. Res. 67 (2005) 216-224
123. Kreher P., Ristori M.T., Corman B., and Verdetti J. Effects of chronic angiotensin I-converting enzyme inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in aging rats. J. Cardiovasc. Pharmacol. 25 (1995) 75-80
124. Kahonen M., Makynen H., Wu A., Arvola P., Pekki A., and Posti I. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension. J. Pharmacol. Exp. Ther. 277 (1996) 1701-1709
125. Yokoshiki H., Kohya T., Tomita F., Tohse N., Nakaya H., Kanno M., et al. Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy. J. Moll. Cell. Cardiol. 29 (1997) 1331-1339
126. Rials S.J., Xu X., Wu Y., Marinchak R.A., and Kowey P.R. Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Am. J. Physiol. 275 (1998) H1216-H1224
127. Kohya T., Yokoshiki H., Tohse N., Kanno M., Nakaya H., Saito H., et al. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade. Circ. Res. 76 (1995) 892-899
128. Cerbai E., Crucitti A., Sartiani L., De Paoli P., Pino R., and Rodorigeuz M.L. Long-term treatment of spontaneous hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes. Cardiovasc. Res. 45 (2000) 388-396
129. Rials S.J., Xu X., Wu Y., Liu T., Marinchak R.A., and Kowey P.R. Restoration of normal ventricular electrophysiology in renovascular hypertensive rabbits after treatment with losartan. J. Cardiovasc. Pharmacol. 37 (2001) 317-323
130. Cerbai E., De Paoli P., Sartiani L., Lonardo G., and Mugelli A. Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive rats. J. Cardiovasc. Pharmacol. 41 (2003) 804-812
131. Martens J.R., Reaves P.Y., Lu D., Katovich M.J., Bereck K.H., Bishop S.R., et al. Pretension of renovasular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2664-2669
132. Perrier E., Kerfant B.G., Lalevee N., Bideaux P., Rossier M.F., Richard S., et al. Mineralcorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation 110 (2004) 776-783
133. Joffe H.V., and Adler G.K. Effects of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail. Res. 10 (2005) 31-37
134. Allan A., Fenning A., Levick S., Hoey A., and Brown L. Reversal of cardiac dysfunction by selective ET-A receptor antagonism. Br. J. Pharmacol. 146 (2005) 846-853
135. Fenning A., Harrison G., Rose'meyer R., Hoey A., and Brown L. l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am. J. Physiol. 289 (2005) H1408-H1416
136. + current in isolated membrane patches of guinea pig ventricular myocytes. Circ. Res. 74 (1994) 96-104
137. + current in cardiac myocytes. Circ. Res. 96 (2005) 64-72
138. Sussman M.A., Lim H.W., Gude N., Taigen T., Olson E.N., Robbins J., et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281 (1998) 1690-1693
139. Schoenmarkers M., Ramakers C., van Opstal J.M., Leunissen J.D., Londono C., and Vos M.A. Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AB block dog. Cardiovasc. Res. 59 (2003) 351-359